NVV1 Stock Price and Chart — FWB:NVV1

Overview

Financials News Ideas Discussions Forecast Seasonals Bonds

Key facts today

Novavax's COVID-19 vaccine shows fewer symptoms than Pfizer-BioNTech's, with recipients reporting an average of 1.7 symptoms versus 2.8, and 24.2% experiencing grade 2 or higher symptoms.

A recent study, known as the Shield-Utah study, has shown that Novavax's COVID-19 vaccine induces lower reactogenicity symptoms compared to mRNA vaccines.

Analyze the impact Analyze the impact

About Novavax, Inc.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

Ideas

See all ideas

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Seasonals

Displays a symbol's price movements over previous years to identify recurring trends.

NVV1 highest yielding bonds

9.44%

Dec 15, 2027

See all NVV1 bonds

Curated watchlists where NVV1 is featured.

Covid vaccine stocks: Jabtastic

Famous meme stocks: Stonks that only go up (apparently)

Reddit stocks: Yolo

Wallstreetbets stocks: Apes together strong

See all sparks

Check out other big names from the same industry as NVV1.

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange NOVAVAX INC stocks are traded under the ticker NVV1.

We've gathered analysts' opinions on NOVAVAX INC future price: according to them, NVV1 price has a max estimate of 22.34 EUR and a min estimate of 8.04 EUR. Watch NVV1 chart and read a more detailed NOVAVAX INC stock forecast: see what analysts think of NOVAVAX INC and suggest that you do with its stocks.

NVV1 reached its all-time high on Feb 8, 2021 with the price of 274.150 EUR, and its all-time low was 3.300 EUR and was reached on Nov 21, 2019. View more price dynamics on NVV1 chart.
See other stocks reaching their highest and lowest prices.

Yes, you can track NOVAVAX INC financials in yearly and quarterly reports right on TradingView.

NOVAVAX INC is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.

NVV1 earnings for the last quarter are −0.49 EUR per share, whereas the estimation was −0.50 EUR resulting in a 0.78% surprise. The estimated earnings for the next quarter are −0.40 EUR per share. See more details about NOVAVAX INC earnings.

NOVAVAX INC revenue for the last quarter amounts to ‪85.31 M‬ EUR, despite the estimated figure of ‪81.51 M‬ EUR. In the next quarter, revenue is expected to reach ‪66.34 M‬ EUR.

NVV1 net income for the last quarter is ‪−78.27 M‬ EUR, while the quarter before that showed ‪−108.94 M‬ EUR of net income which accounts for 28.15% change. Track more NOVAVAX INC financial stats to get the full picture.

No, NVV1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of Apr 15, 2025, the company has 952 employees. See our rating of the largest employees — is NOVAVAX INC on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVAVAX INC EBITDA is ‪−177.20 M‬ EUR, and current EBITDA margin is −26.90%. See more stats in NOVAVAX INC financial statements.

Like other stocks, NVV1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVAVAX INC stock right from TradingView charts — choose your broker and connect to your account.